<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01622478</url>
  </required_header>
  <id_info>
    <org_study_id>GNSBCC001</org_study_id>
    <nct_id>NCT01622478</nct_id>
  </id_info>
  <brief_title>Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph Nodes</brief_title>
  <acronym>VSNBNAC</acronym>
  <official_title>Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy in Breast Cancer Patients With Radiologically Positive Axillary Lymph Nodes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gangnam Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gangnam Severance Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) is currently
      debatable. It is possible that the tumor response to chemotherapy may alter the lymphatic
      drainage thus causing lower SLN identification rate and higher false negative rate. Further,
      the response of NAC can be different in each lymph nodes. It is doubtful whether SLNB can
      accurately predict axillary lymph node (ALN) status after NAC. The aim of this study to
      determine the identification rate, the false-negative rate, and the accuracy of SLNB after
      NAC for node positive breast cancer.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">November 2009</completion_date>
  <primary_completion_date type="Actual">June 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">120</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Clinically node-positive patients before NAC</arm_group_label>
    <description>Patients with clinically positive lymph node receiving neoadjuvant chemotherapy
Clinically negative-node after NAC
Clinically positive-node after NAC</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sentinel lymph node biopsy</intervention_name>
    <description>Sentinel lymph node biopsy after neoadjuvant chemotherapy for the patients with clinically positive-nodes at presentation</description>
    <arm_group_label>Clinically node-positive patients before NAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neoadjuvant chemotherapy</intervention_name>
    <description>Neoadjuvant chemotherapy for breast cancer patients with clinically positive-node at initial diagnosis</description>
    <arm_group_label>Clinically node-positive patients before NAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>complete axillary lymph node dissection</intervention_name>
    <description>Complete axillary lymph node dissection after sentinel node biopsy for estimation of false-negative rate of sentinel node biopsy</description>
    <arm_group_label>Clinically node-positive patients before NAC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>positron emission tomography and ultrasonogram</intervention_name>
    <description>Routine evaluation of axillary nodal status using 18-fluorodeoxyglucose positron emission tomography and ultrasonogram before and after chemotherapy</description>
    <arm_group_label>Clinically node-positive patients before NAC</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Advanced breast cancer patients with node-positive proved in preoperative imaging study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Advanced breast cancer patients with node-positive proved in preoperative imaging
             study

          -  ECOG status 0-1

        Exclusion Criteria:

          -  No previous cancer history

          -  No previous chemotherapy history
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>135270</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 15, 2012</study_first_submitted>
  <study_first_submitted_qc>June 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 19, 2012</study_first_posted>
  <last_update_submitted>August 14, 2012</last_update_submitted>
  <last_update_submitted_qc>August 14, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 15, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gangnam Severance Hospital</investigator_affiliation>
    <investigator_full_name>Sung Gwe Ahn</investigator_full_name>
    <investigator_title>Research Fellow, Breast Cancer Center</investigator_title>
  </responsible_party>
  <keyword>sentinel lymph node biopsy</keyword>
  <keyword>neoadjuvant chemotherapy</keyword>
  <keyword>breast cancer</keyword>
  <keyword>locally advanced breast cancer</keyword>
  <keyword>positive axillary lymph node</keyword>
  <keyword>negative conversion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

